Tandem t:slim X2 pump now suitable with Dexcom G7 in Canada
What you have to know:
– Tandem Diabetes Care, an insulin pump producer, has introduced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– Beneath guarantee customers can now combine their pumps with each the Dexcom G7 and Dexcom G6 Steady Glucose Monitoring (CGM) techniques, offering higher flexibility and selection for diabetes administration.
– Intensive compatibility with Dexcom G6 and G7 additional expands the pump's capabilities and gives customers extra selection and adaptability of their diabetes administration.
Improved selection and adaptability
This replace makes the t:slim X2 pump the primary and solely insulin pump in Canada that’s suitable with each Dexcom G6 and G7. This provides customers the liberty to decide on the CGM system that most accurately fits their wants and preferences.
Advantages of Dexcom G7 Integration
- Quicker heating: The Dexcom G7's 30-minute sensor warm-up time, the quickest in the marketplace, permits customers to spend extra time in closed-loop mode and expertise the advantages of automated insulin supply (AID).
- Smartwatch Compatibility: Customers who pair the Dexcom G7 with an Apple smartwatch can view their glucose ranges instantly on their wrist, providing higher comfort and accessibility.
Seamless improve for current customers
Tandem will present all t:slim X2 customers in Canada who’re underneath guarantee with directions on how one can add the brand new compatibility function without cost by way of a distant software program replace. New t:slim X2 pumps will even be delivered with the up to date software program in early January 2025.
“Via our continued partnership with Tandem, we have now seen the confirmed advantages of automated insulin supply. We’re proud that individuals residing in Canada now have entry to the newest AID choices with Dexcom G7, our smallest and most correct CGM2,” stated André Côté, government vice chairman and basic supervisor of Dexcom Canada. “Our two organizations have the identical core worth: selling technological innovation that results in a greater life for individuals with diabetes. We couldn't be extra excited to formally convey this provide to Canadians.”